• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

狼疮性肾炎和系统性红斑狼疮区域及国家住院负担的异质性。

Heterogeneity of regional and national hospitalization burden of lupus nephritis and systemic lupus erythematous.

作者信息

Avello Alejandro, Fernández-Prado Raúl, Abasheva Daria, Mahillo Ignacio, González-Gay Miguel Ángel, Martín-Cleary Catalina, Arce-Obieta José Miguel, Pérez-Gómez María Vanessa, Fernández-Fernández Beatriz, Ortiz Alberto

机构信息

Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain.

RICORS2040, Madrid, Spain.

出版信息

Clin Kidney J. 2025 Jul 1;18(7):sfaf162. doi: 10.1093/ckj/sfaf162. eCollection 2025 Jul.

DOI:10.1093/ckj/sfaf162
PMID:40625697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12230550/
Abstract

BACKGROUND

Differences between regional healthcare systems in the in-hospital burden and care of systemic lupus erythematosus (SLE) and lupus nephritis (LN) are poorly characterized. Their analysis may provide benchmarking opportunities that improve the quality and sustainability of care.

METHODS

We retrospectively investigated the hospitalization burden of SLE and LN in 2019-2021 across Spanish regional healthcare systems using the Spanish National Hospital Discharge Records database (RAE-CMBD) and National Statistics Institute (INE) data.

RESULTS

Of 66 262 724 hospitalization episodes from 644 public and private hospitals, 10 781 had a primary diagnosis of SLE, of which 2481 (23%) were for LN. The mean annual nationwide hospitalization case incidence was 70.61 and 1.75 per 100 000 population for SLE and LN, respectively. Regional differences were large: 48.0-fold and 6.9-fold between regions with the highest and lowest incidence for SLE and LN, respectively. In multivariate analysis, net household income and percentage of foreign-born population were associated with the number of SLE and LN hospitalization episodes. Internal medicine managed 28% of SLE and 15% of LN hospitalizations, nephrology 14% and 56% and rheumatology 23% and 11%, respectively, but there were large regional differences. The mean SLE and LN stays were 8.85 and 6.92 days (5.47 and 5.41 for nephrology and 11.18 and 11.83 for internal medicine), respectively. The average all patient refined diagnosis related groups (APR-DRGs) cost per episode was €2408 for SLE and €3563 for LN. The average yearly costs were €167 985 per million population (pmp) for SLE hospitalizations (4.32-fold differences between regions) and €60 825 pmp for LN hospitalizations (4.20-fold differences between regions). Large differences between regions were observed in the cost burden pmp relative to household income (4.70-fold for LN and 4.13-fold for SLE).

CONCLUSION

In real-world clinical practice, the burden of in-hospital care of LN and SLE is heterogeneous across and within regional healthcare systems, offering the opportunity to benchmark best practice, optimize care and improve outcomes.

摘要

背景

系统性红斑狼疮(SLE)和狼疮性肾炎(LN)在不同地区医疗系统中的院内负担及护理差异鲜有描述。对这些差异进行分析可能会提供改善护理质量和可持续性的基准制定机会。

方法

我们利用西班牙国家医院出院记录数据库(RAE-CMBD)和国家统计局(INE)的数据,回顾性调查了2019年至2021年西班牙各地区医疗系统中SLE和LN的住院负担。

结果

在644家公立和私立医院的66262724次住院病例中,10781例主要诊断为SLE,其中2481例(23%)为LN。全国范围内SLE和LN的年平均住院病例发病率分别为每10万人70.61例和1.75例。地区差异很大:SLE发病率最高和最低的地区之间相差48.0倍,LN相差6.9倍。在多变量分析中,家庭净收入和外国出生人口百分比与SLE和LN的住院病例数相关。内科管理了28%的SLE住院病例和15%的LN住院病例,肾脏病科分别为14%和56%,风湿病科分别为23%和11%,但地区差异很大。SLE和LN的平均住院天数分别为8.85天和6.92天(肾脏病科分别为5.47天和5.41天,内科分别为11.18天和11.83天)。SLE每次住院的平均所有患者精细诊断相关组(APR-DRGs)费用为2408欧元,LN为3563欧元。SLE住院的年平均费用为每百万人口167985欧元(各地区之间相差4.32倍),LN住院为每百万人口60825欧元(各地区之间相差4.20倍)。各地区之间在相对于家庭收入的每百万人口成本负担方面存在很大差异(LN为4.70倍,SLE为4.13倍)。

结论

在实际临床实践中,LN和SLE的院内护理负担在地区医疗系统内部和之间存在异质性,这为制定最佳实践基准、优化护理和改善结局提供了机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df5/12230550/98611eab1cf4/sfaf162fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df5/12230550/87125842bcfb/sfaf162fig1g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df5/12230550/f153c4fcde86/sfaf162fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df5/12230550/98611eab1cf4/sfaf162fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df5/12230550/87125842bcfb/sfaf162fig1g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df5/12230550/f153c4fcde86/sfaf162fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df5/12230550/98611eab1cf4/sfaf162fig3.jpg

相似文献

1
Heterogeneity of regional and national hospitalization burden of lupus nephritis and systemic lupus erythematous.狼疮性肾炎和系统性红斑狼疮区域及国家住院负担的异质性。
Clin Kidney J. 2025 Jul 1;18(7):sfaf162. doi: 10.1093/ckj/sfaf162. eCollection 2025 Jul.
2
Definition and application of systemic lupus erythematosus disease modification in emerging markets: Delphi panel consensus recommendations.新兴市场中系统性红斑狼疮疾病修饰的定义与应用:德尔菲专家小组共识建议
Lupus. 2025 Aug;34(9):899-911. doi: 10.1177/09612033251347341. Epub 2025 Jun 6.
3
Hypertension, proteinuria, and RAAS inhibition use in children with systemic lupus erythematosus: Data from a multi-institutional pediatric learning health system.系统性红斑狼疮患儿的高血压、蛋白尿及肾素-血管紧张素-醛固酮系统抑制剂的使用:来自多机构儿科学习健康系统的数据
Lupus. 2025 Jul;34(8):832-843. doi: 10.1177/09612033251345201. Epub 2025 May 20.
4
Genetic contributions to lupus nephritis in a multi-ethnic cohort of systemic lupus erythematous patients.遗传因素在多民族系统性红斑狼疮患者狼疮肾炎中的作用。
PLoS One. 2018 Jun 28;13(6):e0199003. doi: 10.1371/journal.pone.0199003. eCollection 2018.
5
Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and systemic lupus erythematosus/lupus nephritis: a systematic review and metaanalysis.血管紧张素转换酶插入/缺失基因多态性与系统性红斑狼疮/狼疮性肾炎的关系:系统评价和荟萃分析。
J Rheumatol. 2012 Apr;39(4):686-93. doi: 10.3899/jrheum.110863. Epub 2012 Feb 15.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Urodynamics tests for the diagnosis and management of male bladder outlet obstruction: long-term follow-up of the UPSTREAM non-inferiority RCT.用于男性膀胱出口梗阻诊断和管理的尿动力学检查:UPSTREAM非劣效性随机对照试验的长期随访
Health Technol Assess. 2025 Jul;29(26):1-57. doi: 10.3310/SLPT4675.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
Management of newly diagnosed lupus nephritis in China: An implementation study based on the 2023 EULAR recommendations.中国新诊断狼疮性肾炎的管理:一项基于2023年欧洲抗风湿病联盟(EULAR)建议的实施研究
Clin Rheumatol. 2025 Jun 7. doi: 10.1007/s10067-025-07520-x.
10
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.

本文引用的文献

1
Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.放疗在食管、胃、结肠、直肠、肝、胰腺、肺和卵巢癌患者中的应用:国际癌症基准合作组织(ICBP)基于人群的研究。
Lancet Oncol. 2024 Mar;25(3):352-365. doi: 10.1016/S1470-2045(24)00032-9.
2
EULAR 2023 recommendations for SLE treatment: synopsis for the management of lupus nephritis: the European Renal Association-Immunonephrology Working Group (ERA-IWG) perspective.欧洲抗风湿病联盟(EULAR)2023年系统性红斑狼疮治疗推荐:狼疮性肾炎管理概要:欧洲肾脏协会-免疫肾脏病学工作组(ERA-IWG)观点
Nephrol Dial Transplant. 2024 Apr 26;39(5):727-730. doi: 10.1093/ndt/gfad230.
3
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.EULAR 推荐的系统性红斑狼疮治疗:2023 更新版。
Ann Rheum Dis. 2024 Jan 2;83(1):15-29. doi: 10.1136/ard-2023-224762.
4
Diagnosis and treatment of lupus nephritis: a summary of the Consensus Document of the Spanish Group for the Study of Glomerular Diseases (GLOSEN).狼疮性肾炎的诊断与治疗:西班牙肾小球疾病研究组(GLOSEN)共识文件总结
Clin Kidney J. 2023 Mar 22;16(9):1384-1402. doi: 10.1093/ckj/sfad055. eCollection 2023 Sep.
5
Health Care Utilization in Systemic Lupus Erythematosus in the Community: The Lupus Midwest Network.社区中系统性红斑狼疮的医疗保健利用:狼疮中西部网络。
J Clin Rheumatol. 2023 Jan 1;29(1):29-35. doi: 10.1097/RHU.0000000000001899. Epub 2022 Oct 1.
6
Trends in Hospital Admissions and Death Causes in Patients with Systemic Lupus Erythematosus: Spanish National Registry.西班牙国家登记处:系统性红斑狼疮患者的住院趋势及死亡原因
J Clin Med. 2021 Dec 8;10(24):5749. doi: 10.3390/jcm10245749.
7
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases.KDIGO 2021肾小球疾病管理临床实践指南。
Kidney Int. 2021 Oct;100(4S):S1-S276. doi: 10.1016/j.kint.2021.05.021.
8
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.2019 年更新版欧洲抗风湿病联盟与欧洲肾脏学会-欧洲透析和移植学会(EULAR/ERA-EDTA)狼疮肾炎管理建议。
Ann Rheum Dis. 2020 Jun;79(6):713-723. doi: 10.1136/annrheumdis-2020-216924. Epub 2020 Mar 27.
9
Update on Lupus Nephritis: Core Curriculum 2020.狼疮肾炎更新:2020 年核心课程。
Am J Kidney Dis. 2020 Aug;76(2):265-281. doi: 10.1053/j.ajkd.2019.10.017. Epub 2020 Mar 24.
10
Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry).两组西班牙裔人群(欧洲白人与拉丁美洲混血儿)的系统性红斑狼疮临床表现差异及疾病严重程度增加:来自 RELSER 登记研究的数据。
Lupus. 2020 Jan;29(1):27-36. doi: 10.1177/0961203319889667. Epub 2019 Dec 4.